Summary A human malignant pleural mesothelioma was xenografted serially in athymic nude Rowett rats for 27 passages during 33 months. After the two initial passages (P), the take rate during P3-9 was 100% (192/192). The tumour grew progressively during P3-9 in 99% (190/192) and regressed totally in 1% (2/192). The take rate for the tumour xenografted to athymic BALB/c mice was also 100% (17/17) and no regressions were observed. During serial passaging in nude rats, the tumour-volume doubling time (TD) decreased from 6 days in P2 to 3 days in P8-9 (P<0.001) and then remained around 3 days during P10-25. A TD of 11 days in P1 (man-mouse) for tumours grown in mice decreased during 10 passages in rats to 4 days (P<0.005) when the tumour was transplanted to mice in P11. Light microscopic morphology of the tumour was retained in rats and mice. We believe that our experimental tumour model using the nude rat as a carrier of the xenograft will be useful for studies of human mesothelioma.
Malignant human pleural mesothelioma (MHPM) is a rare tumour with a poor prognosis. The evaluation of chemoand radiotherapy is difficult in MHPM owing to difficulties in measuring the tumour volume, lack of a generally accepted staging system (Dimitrov et al., 1983) and different prognoses in the three main histologic subtypes of this tumour (Elmes & Simpson, 1976) .
Growth of human tumour xenografts in athymic nude mice or artificially immunosuppressed mice is regarded as the best currently available experimental model for studying the response of human tumours to drugs (Pihl, 1986) . Most human malignant tumours, including pleural mesotheliomas (Chahinian et al., 1980; Linden et al., 1982) , have been xenografted to athymic mice. Festing et al. (1978) described an athymic nude rat with an immunodeficiency state comparable to that of the athymic mouse, suggested to be more robust for certain experimental situations, e.g., for experiments requiring surgical manipulations and frequent blood sampling.
Experience with the athymic rat is sparse compared to that with the athymic mouse, but many human malignant tumours, including one human malignant pleural mesothelioma (Linden et al., 1982) , have been successfully xenografted to rats.
In the present study we transplanted another MHPM to both athymic rats and mice and studied the long-term growth pattern of this tumour line in nude rats. We also compared the growth pattern of the tumour in athymic mice and rats.
Materials and methods

Tumour
A 66-year old man was found to have an epithelial pleural mesothelioma at thoracoscopic biopsy of the parietal pleura.
The tumour was treated with irradiation to a total dose of 40 Gy. About 2 weeks after the completion of the radiotherapy against the diseased hemithorax, an implantation metastasis was noted in the former needle tracks. This tumour nodule was excised and used for establishing this (AKG) tumour cell line. The patient was treated further with 3 courses of combined chemotherapy consisting of doxorubicin and cyclophosphamide, but in spite of this treatment the tumour progressed and he died. At 
Tumour morphology
Tissue from the primary tumour in the pleural cavity was examined and compared with tumour tissue from xenografts grown in rats in passage 1, 19 and 26 and in mice in passage I and 11. Formalin-fixed and paraffin-embedded blocks were used. The sections were stained with haematoxylin-eosin, van Gieson, alcian blue (pH 2.5) before and after hyaluronidase digestion and PAS (periodic acid-Schiff) before and after diastase digestion (D-PAS).
Immunohistochemistry Formalin-fixed and paraffin embedded blocks were used with the peroxidase-antiperoxidase (PAP) method using rabbit-antibodies directed against two different cytokeratins, CAM 5.2 (B&D) and AE1/AE3 In the first passage (man-animal) 1 g tumour suspension was injected into each animal, rats as well as mice. In a second passage in rats 1.6 g of tumour suspension were injected into each animal. From the third transplantation generation all further inoculations in rats, as well as in mice, were made with 0.5 g of tumour suspension dissolved in 0.5 ml sterile isotonic saline per animal. Figure 1 ). Staining for neutral mucins with PASdiastase was negative, as was staining for acid mucins with alcian blue-hyaluronidase (pH 2.5). Varying degrees of necrosis were seen in the primary tumour and in the xenografts in rats and mice, but were unrelated to tumour generation or tumour bearing species.
The immunoreactivity was recorded as strong or moderate for cytokeratin and EMA and absent for CEA, vimentin and desmin. The staining pattern was retained in the xenografts in rats and mice.
Transplantation
The tumour was serially passaged in rats for a total of 27 generations over 33 months. In the first passage (P) (mananimal) the tumour suspension was inoculated into mice and rats (Figure 2) . The serial propagation, however, was carried out exclusively in rats. The take rate in rats was 93% (13/14) in the 2 initial passages and 100% (192/192) in P3-9. Likewise, in mice inoculated with the tumour (P1 and P11) the take rate was 100% (17/17).
One percent (2/205) of the tumours growing in rats regressed totally during P1-P9 and none in mice (0/17) (P1 and Pll). Thus, there was no statistically significant difference between rats and mice regarding rates of take and regression. The tumour volume doubling time (TD) decreased during serial passage in rats from 6 days in P2 to 3 days in P8-9 (P<0.001) (Figure 3 ), but was then retained at around 3 days during further passaging in rats (P10-25) (P>0.05) (Figure 4) . The time to reach a specified tumour volume (TV) gives a total measure of the latency time for tumour growth and the TD. The tumour reached a TV of 2cm3 after 36 days in P2 and this decreased to 15-16 days in P8-9 (P<0.001) and to 11-12 days in PIO-12; after that no further decrease was observed in passages P1O-P25.
To investigate if the increased growth rate in rats was species-dependent, we transferred tumour tissue from rats in PlO to mice (P11) (Figure 2 ) and compared the growth parameters in mice with those in rats before and after one tumour generation in mice. The TD in mice (P1 1), 4.2 days at low TV (1-3 cm3), was not significantly different (P=0.03) from that in rats (3.6 days) in P10-12. However, for larger tumours (TV>3cm3), the TD in rats (3.6 days), compared to mice (9.3 days), was shorter (P<0.001). In addition, the TVs were larger in rats than in mice (P<0.0001), as illustrated in Figure 2 . The TD for the tumour grown in mice in P1 decreased from 11 days to 4 days in P11 (P<0.005) (Figure 2 ) and the time for the tumour to grow to 4cm3 decreased from 79 days to 26 days (P< 0.005).
Discussion
The tumour was classified as an epithelial pleural mesothelioma according to established criteria (World Health Organization, 1981) . The immunohistochemical staining pattern was characteristic for an epithelial mesothelioma with absence of CEA and strong to moderate reactivity to cytokeratins (Otis et al., 1987) .
The xenografted tumour retained its histologic pattern and its tumour antigens during 27 serial tumour generations in rats and was not changed by transfer of the tumour to mice for one generation. This preservation of the tumour morphology is in agreement with observations in nude mice that human mesothelioma xenografts have retained their tumour morphology during long-time serial passaging (Suzuki et al., 1987) . However, in experimentally induced animal mesotheliomas, changes have been reported in the dominating morphologic cell type of the tumour during serial passaging in animals (Wagner et al., 1982) .
In a comparison of the usefulness of nude rats versus nude mice, it is important to evaluate the take rates of xenografted tumours. In our mesothelioma tumour line, the take rate was roughly 100% in both nude rats and mice. However, no direct assessment of the lowest cell number required for tumour take was made; this would have made a more precise evaluation possible. The take rates for cells from previously serially transplantable tumour lines or from primary explants have been reported to be equal in rats and mice (Sawada et al., 1982; Matthews et al., 1982) . However, in a few studies the take rates have been observed to be lower in nude rats (Maruo et al., 1982; Giovanella et al., 1984) . In addition, the take rate (Sawada et al., 1982; Maruo et al., 1982; Drewinko et al., 1986 ) and growth rate (Maruo et al., 1982) of xenografts in nude rats have been observed to decrease with increasing age in the animal. This decrease of take rate and growth rate is thought to be related to the observed increase of host NK cell activity with ageing in the nude rat (Lotzova et al., 1984) .
The adaptive alterations of the internal properties of the xenografted tumour are important, in addition to the interaction with the host. Our observation of an initial decrease of the TD of the tumour grown in rats during the first 8-9 passages and a conservation of the growth rate during 18 further passages in rats is in agreement with reports of human tumours serially transplanted in nude mice (Mattern et al., 1980) and in immunodeficient mice (Houghton & Taylor, 1978) . After the initial decrease in TD of xenografted tumours in nude mice, the growth rate has remained fairly constant for long periods (Povlsen et al., 1975) . However, in a few tumours growth rate has been observed to increase in later passages after an initial period of constant growth rate (Fodstad et al., 1980) . This increase in the growth rate of the xenografted tumour may also be accompanied by an increased sensitivity to chemotherapeutic agents (Fodstad et al., 1983) .
In an attempt to investigate if the increase in growth rate during the initial passages in rats was a species-dependent adaptation to the xenograft state in rats, we transferred the tumour grown serially in rats for 10 generations to mice for one passage and then retransplanted the tumour to rats (Figure 2) . The tumour grew with approximately the same TD when grown in rats before and after one tumour generation in mice. At low tumour volumes the TD was the same in the 11th passage in mice as in the corresponding passages in rats. However, the TD for tumours grown in mice in 11 M was significantly shorter than for tumours grown in mice in the first passage (IM).
Our observations thus indicate that after the initial adaptation to the xenograft environment, the growth rate of the tumour as a xenograft is not species-dependent in this tumour line at low tumour volumes. Also the TTV 4cm3, as Time after transplantation (days) Figure 2 Growth curves of mesothelioma AKG xenografted to athymic rats (R) and athymic mice (M). In the first passage 1 g tumour tissue from a chest-wall metastasis was transplanted to each of 3 rats (0 IR) and 4 mice (O IM). From tumour tissue grown in the 10th generation in rats (X IOR, n= 14), 0.5g tumour tissue was transferred in the 11th passage to each of 12 rats ( IiR) and 13 mice (l 1iM). Tumour tissue grown in mice in the 11th passage (1 M) was retransplanted to rats in passage 12 (A 12BR, n = 9). Concurrently, tumour tissue grown in the 11th passage in rats was further transplanted to rats in the 12th passage (1l2AR, n= -1). Circles and squares represent mean and vertical bars represent s.d. a combined measure of TD and lag time for tumour growth, decreased significantly in mice after 10 passages in rats (Figure 2 ). The reduced latency time for tumour growth in rats (Figure 2) was not influenced by one tumour generation in mice, supporting our hypothesis of a species independence of the internal growth rate of the xenograft at low tumour volumes. In contrast, the latency time for tumour growth in our tumour seems to be significantly shorter in rats than in mice (Figure 2) . This is in agreement with observations that some tumours may grow significantly faster in rats than in mice (Giovanella et al., 1984 (Brunton & Wheldon, 1978) . Theoretical calculations of the maximal achievable tumour volumes of human tumour xenografts in mice using the Gompertz equation indicate maximal volumes to be in the range of those actually found in mouse tumours (Rofstad et al., 1982) .
We found that at tumour volumes above 3-5 cm3 the tumour growth rate in mice was significantly lower than in rats. We suggest that the most probable explanation of the lower tumour growth rate in mice at larger tumour volumes is the lower body weight of the mice and not host factors of an immunological nature. Regressions of progressively growing human tumour xenografts have rarely been described in nude mice. In contrast, early regression and regression after several months of progressive growth are known in nude rats (Colston et al., 1981; Stragand et al., 1982) . We observed only 2 complete tumour regressions in 205 tum6urs which grew in nude rats and none in 17 nude mice. This indicates that the regression rate in 4-8 week old nude rats roughly corresponds to that in adult nude mice in this tumour line, although the number of inoculated mice was far too few to permit detection of minor differences.
The rate of tumour takes and regressions of growing tumours in nude rats has been reported to be related to host NK cell activity (Drewinko et al., 1986) . Recently, it has been observed that the NK cell activity in athymic rats is age dependent, virtually absent in rats less than 3 weeks of age and found to increase to adult levels at 7-10 weeks of age (Lotzova et al., 1984) .
This age dependency of the NK cell activity might explain part of the reported variations in rates of take and regression.
In conclusion, we have transplanted a human pleural mesothelioma for 27 passages in athymic rats over a period of 33 months. The tumour increased its growth rate during the initial passages in rats and then retained its growth rate for nearly 20 passages. This tumour also grew in nude mice with a longer latency time for tumour growth than in rats, but with the same growth rate at low tumour volumes. We believe that the nude rat is a useful and robust carrier of our mesothelioma xenograft and that the stable growth of this tumour in nude rats will make the system useful for experimental studies including drug testing.
